Anandasabapathy, N
Breton, G
Hurley, A
Caskey, M
Trumpfheller, C
Sarma, P
Pring, J
Pack, M
Buckley, N
Matei, I
Lyden, D
Green, J
Hawthorne, T
Marsh, H C
Yellin, M
Davis, T
Keler, T
Schlesinger, S J
Article History
Received: 23 September 2014
Revised: 5 February 2015
Accepted: 19 February 2015
First Online: 27 April 2015
Competing interests
: JG, TH, HCM, MY, TD and TK are employed by and hold stock options in Celldex Therapeutics, Inc. SS is on the board of directors and holds stock in Ariad. The remaining authors declare no conflict of interest.